Overview

A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

Status:
COMPLETED
Trial end date:
2024-10-08
Target enrollment:
Participant gender:
Summary
The purpose of this clinical study is to evaluate the pharmacokinetic, pharmacodynamic characteristics and the safety after administration by doses of "BR1400-1", "BR1400-2", "BR1400-3" in healthy volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd